Skip to main content
. 2021 Sep 28;12(20):2075–2088. doi: 10.18632/oncotarget.28060

Table 4. 3-year overall and progression-free survival in 28 patients after radioembolization for intrahepatic cholangiocarcinoma.

Parameter Overall survival (%) in Months Progression-Free survival (%) in Months
6 12 18 24 30 p-value 6 12 18 24 30 p-value
All Patients 96 78 67 59 59 74 45 40 25 25
Anatomic Distribution 0.403 0.003
 Segmental (n = 9) 88 88 88 59 59 88 88 88 59 59
 Unilobar (n = 8) 100 83 83 83 83 878 39 39 39 39
 Bilobar (n = 11) 100 68 43 43 43 55 18 9 0 0
Tumor Focality 0.112 0.002
 Solitary (n = 16) 93 85 85 85 85 87 63 63 63 63
 Multifocal (n = 12) 100 71 49 37 37 58 25 17 0 0
Tumor Morphology 0.002 0.382
 Mass Forming (n = 22) 95 90 77 68 68 67 52 46 29 29
 Periductal/intraductal (n = 6) 100 0 0 0 0 100 11 0 0 0